Compound information
- Natural Products
- ZC2650521
- Molecular Formula
- C22H22FN5O3
- Molecular Weight
- 423.170667784 g/mol
- Structure
-
- IUPAC Name
- N-[3-[[5-fluoro-2-[4-(2-methoxyethoxy)anilino]pyrimidin-4-yl]amino]phenyl]prop-2-enamide
- InChI
- InChI=1S/C22H22FN5O3/c1-3-20(29)25-16-5-4-6-17(13-16)26-21-19(23)14-24-22(28-21)27-15-7-9-18(10-8-15)31-12-11-30-2/h3-10,13-14H,1,11-12H2,2H3,(H,25,29)(H2,24,26,27,28)
- InChI Key
- KXBDTLQSDKGAEB-UHFFFAOYSA-N
- SMILES
- C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(OCCOC)cc3)ncc2F)c1
- Source
- ZINC000072319585
Warheads
- Acrylamide
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 31 | Ring Count | 3 |
Heteroatom Count | 9 | Rotatable Bond Count | 10 |
Hydrogen Bond Acceptor Count | 7 | Hydrogen Bond Donor Count | 3 |
Topological Polar Surface Area | 97.4 Å2 | LogP | 3.994 |
LogS | -4.183 | LogD | 3.469 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.099 | Pgp substrate | 0.532 |
HIA | 0.957 | F20 % | 0.971 |
F30 % | 0.141 | Caco-2 | -4.636 |
MDCK | -4.82 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.108 | PPB | 93.276 |
VD | 0.861 | Fu | 1.768 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.964 | CYP1A2 substrate | 0.719 |
CYP2A6 substrate | 0.471 | CYP2B6 substrate | 0.588 |
CYP2C19 inhibitor | 0.608 | CYP2C19 substrate | 0.887 |
CYP2C8 substrate | 0.878 | CYP2C9 inhibitor | 0.049 |
CYP2C9 substrate | 0.93 | CYP2D6 inhibitor | 0.943 |
CYP2D6 substrate | 0.893 | CYP2E1 substrate | 0.367 |
CYP3A4 inhibitor | 0.907 | CYP3A4 substrate | 0.793 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.156 | CL | 7.895 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.182 | Hepatotoxicity | 0.997 |
Mutagenicity | 0.375 | Rat Oral Acute Toxicity | 0.09 |
FDAMDD | 0.688 | Skin Sensitization | 0.896 |
Carcinogenicity | 0.111 | Eye Corrosion | 0.002 |
Eye Irritation | 0.001 | Respiratory Toxicity | 0.722 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 1.606 | IGC50 | 3.892 |
LC50FM | 3.38 | LC50DM | 4.874 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.697 | NR-AR-LBD | 0.427 |
NR-AhR | 0.926 | NR-Aromatase | 0.351 |
NR-ER | 0.89 | NR-ER-LBD | 0.635 |
NR-PPAR-gamma | 0.922 | SR-ARE | 0.953 |
SR-ATAD5 | 0.89 | SR-HSE | 0.902 |
SR-MMP | 0.972 | SR-p53 | 0.935 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.